Skip to content
Search

Latest Stories

Boots to offer £42k FTE base salary to newly-qualified pharmacists

Boots UK will offer a staring salary of £42,000 per annum to newly qualified pharmacists joining the pharmacy chain.

The company also revealed that "in addition, any existing pharmacists in the bargaining unit currently receiving less than £43k.”


The newly announced hike in the salary -- following an agreement reached between the multiple and and the Pharmacist Defence Association -- will be effective from 1 August 2022.

“This enhanced offer for Newly Qualified Pharmacists and further investment in those in the early stages of their careers at Boots is a key part of our commitments to pharmacists,” the company said.

Boots and PDA Union also announced in a joint statement that they will conduct a further formal review of all pharmacists’ pay in accordance with the collective agreement, effective from 1 November 2022.

“Those receiving this adjustment to £43k will remain part of the November 2022 pay review. Details of the November 2022 pay review will be shared in due course once this year’s pay negotiations have taken place.”

Newly-qualified Boots pharmacists' salary in past 10 years

“When the PDA Union explained to pharmacists the potential benefits of union recognition at Boots before the ballots, a significant issue identified was that NQ pharmacists starting salaries had been suppressed for many years. In the entire 10 years before union recognition, NQ starting salaries had increased by just 3 per cent (2007: £33,000 to 2018: £34,000),” said PDA.

"For the last 10 years, salaries for newly-qualified Boots pharmacists have remained almost static."

In 2007, Boots newly qualified pharmacist were offered £33,000; equivalent salary in 2017, taking into account inflation: Circa £43,527 and actual Boots newly qualified pharmacist salary 2017/18: £34,000.

“In addition, hundreds of Boots pharmacists have been disadvantaged by market-based pay which was introduced in 2014. Pharmacists’ salaries are based on undisclosed “market data” from an unspecified source,” said PDA.

“We think pharmacists should be told exactly how their salaries are being determined, and have the opportunity to negotiate better ones.”

“However, in the four years since pharmacists secured the rights to collective bargaining, these starting rates have increased by 23.5% (2018: £34,000 to 2022: £42,000). Union negotiators have also agreed with Boots that any increase to NQ pharmacist salaries cannot place NQ pharmacists on higher salaries than established colleagues, something that was not publicly guaranteed when the company decided pay rates by itself.”

While the PDA Union believes that the NQ pharmacist rates increase will significantly increase income for some lower-paid pharmacists in the bargaining unit, others will see no increase as a result of this.

The PDA Union, therefore, recognises that these increases do have an impact on differentials, closing the pay gap between brand-new pharmacists and their more experienced colleagues.

Those who have not benefitted significantly or at all under this proposal in the forthcoming pay review will be on the Union's priority.

The Union will also seek to ensure members at Boots are actively encouraged to provide their opinions to the union negotiators before the claim is finalised.

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Dr Penelope Dash new chair of NHS England

Dr Penny Dash is currently the chair of the NHS North West London Integrated Care Board

parliamentlive

Dr Penelope Dash appointed as new chair of NHS England

Dr Penny Dash has been appointed as the next chair of NHS England following an open public appointment process.

She will succeed Richard Meddings, who is set to step down next month, and her four-year term begins on April 1, 2025.

Keep ReadingShow less